181 related articles for article (PubMed ID: 35971665)
1. Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance.
Fong W; Timms V; Sim E; Pey K; Nguyen T; Sintchenko V
J Antimicrob Chemother; 2022 Oct; 77(11):3016-3025. PubMed ID: 35971665
[TBL] [Abstract][Full Text] [Related]
2. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
[TBL] [Abstract][Full Text] [Related]
4. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
[TBL] [Abstract][Full Text] [Related]
5. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99].
Chodorowska M; Kuklińska D; Tyski S
Med Dosw Mikrobiol; 2001; 53(1):39-43. PubMed ID: 11757403
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
Lönnqvist E; Barkoff AM; Mertsola J; He Q
J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
[TBL] [Abstract][Full Text] [Related]
7. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
Lin X; Zou J; Yao K; Li L; Zhong L
Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
[TBL] [Abstract][Full Text] [Related]
8. Macrolide-Resistant Bordetella pertussis, Vietnam, 2016-2017.
Kamachi K; Duong HT; Dang AD; Hai T; Do D; Koide K; Otsuka N; Shibayama K; Hoang HTT
Emerg Infect Dis; 2020 Oct; 26(10):2511-2513. PubMed ID: 32946738
[TBL] [Abstract][Full Text] [Related]
9. The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Yamaguchi T; Kawasaki Y; Katsukawa C; Kawahara R; Kawatsu K
Jpn J Infect Dis; 2020 Sep; 73(5):361-362. PubMed ID: 32350216
[TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
Li L; Deng J; Ma X; Zhou K; Meng Q; Yuan L; Shi W; Wang Q; Li Y; Yao K
Emerg Infect Dis; 2019 Dec; 25(12):2205-2214. PubMed ID: 31742507
[TBL] [Abstract][Full Text] [Related]
11. The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study.
Wang Z; Luan Y; Du Q; Shu C; Peng X; Wei H; Hou T; Liu Y; Liu X; Li Y
BMC Infect Dis; 2020 Aug; 20(1):615. PubMed ID: 32814558
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting analysis for the detection of two erythromycin-resistant Bordetella pertussis strains carried by healthy schoolchildren in China.
Zhang Q; Li M; Wang L; Xin T; He Q
Clin Microbiol Infect; 2013 Jun; 19(6):E260-2. PubMed ID: 23480481
[TBL] [Abstract][Full Text] [Related]
13. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains.
Mazengia E; Silva EA; Peppe JA; Timperi R; George H
J Clin Microbiol; 2000 Jun; 38(6):2330-3. PubMed ID: 10834997
[TBL] [Abstract][Full Text] [Related]
14. Direct Detection of Erythromycin-Resistant Bordetella pertussis in Clinical Specimens by PCR.
Wang Z; Han R; Liu Y; Du Q; Liu J; Ma C; Li H; He Q; Yan Y
J Clin Microbiol; 2015 Nov; 53(11):3418-22. PubMed ID: 26224847
[TBL] [Abstract][Full Text] [Related]
15. Co-infection with two different strains of Bordetella pertussis in an infant.
Cassiday PK; Tobin-D'Angelo M; Watson JR; Wu KH; Park MM; Sanden GN
J Med Microbiol; 2008 Mar; 57(Pt 3):388-391. PubMed ID: 18287306
[TBL] [Abstract][Full Text] [Related]
16. Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.
Cai J; Chen M; Liu Q; Luo J; Yuan L; Chen Y; Chen M; Zeng M
Int J Antimicrob Agents; 2023 Jul; 62(1):106835. PubMed ID: 37127126
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of pertussis in Casablanca (Morocco): contribution of conventional and molecular diagnosis tools.
Katfy K; Guiso N; Diawara I; Zerouali K; Slaoui B; Jouhadi Z; Zineddine A; Belabbes H; Elmdaghri N
BMC Infect Dis; 2017 May; 17(1):348. PubMed ID: 28511667
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
[TBL] [Abstract][Full Text] [Related]
19. Macrolide susceptibility and molecular characteristics of
Zhang J; Zhang D; Wang X; Wei X; Li H
J Int Med Res; 2022 Feb; 50(2):3000605221078782. PubMed ID: 35225710
[TBL] [Abstract][Full Text] [Related]
20. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.
Bartkus JM; Juni BA; Ehresmann K; Miller CA; Sanden GN; Cassiday PK; Saubolle M; Lee B; Long J; Harrison AR; Besser JM
J Clin Microbiol; 2003 Mar; 41(3):1167-72. PubMed ID: 12624047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
